Co-Creation of a Lanreotide Autogel/Depot Syringe for the Treatment of Acromegaly and Neuroendocrine Tumours Through Collaborative Human Factor Studies

INTRODUCTION: Although the previous lanreotide autogel/depot syringe had been well received, feedback indicated that improvements could be made to make it more user-friendly. Additionally, the view that patients should have greater involvement in the research and development process is echoed by the...

Descripción completa

Detalles Bibliográficos
Autores principales: Adelman, Daphne T., Van Genechten, Dirk, Megret, Clémentine M., Truong Thanh, Xuan-Mai T., Hand, Philippa, Martin, Wendy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860467/
https://www.ncbi.nlm.nih.gov/pubmed/31612358
http://dx.doi.org/10.1007/s12325-019-01112-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860467/
https://www.ncbi.nlm.nih.gov/pubmed/31612358
http://dx.doi.org/10.1007/s12325-019-01112-3

Ejemplares similares